Atrial septal defect closure with left ventricular dysfunction

Victor-Xavier Tadros1, Anita W Asgar

  • 1Interventional Cardiology, Department of Medicine, Montreal Heart Institute, Université de Montréal, Montréal, QC, Canada.

Insights

Transcatheter closure of atrial septal defects (ASD) is standard, but carries risks in adults with left ventricular dysfunction. This review covers managing ASD closure in these patients to minimize complications.

Area of Science:

  • Cardiology
  • Congenital Heart Disease
  • Interventional Cardiology

Background:

  • Atrial septal defects (ASD) are common adult congenital heart diseases, often causing left-to-right shunts.
  • Undiagnosed ASDs can lead to significant hemodynamic changes and symptoms in adulthood.
  • Transcatheter ASD closure is preferred, but carries risks in patients with left ventricular (LV) dysfunction due to pressure changes.

Purpose of the Study:

  • To review clinical aspects of transcatheter ASD closure in adults with LV dysfunction.
  • To discuss risk evaluation methods for these complex patients.
  • To outline strategies for minimizing complications during ASD closure.

Main Methods:

  • Review of current literature on transcatheter ASD closure.
  • Analysis of hemodynamic implications in patients with LV dysfunction.
  • Discussion of risk stratification and management strategies.

Main Results:

  • Transcatheter ASD closure in LV dysfunction requires careful patient selection and monitoring.
  • Acute hemodynamic shifts can precipitate complications in vulnerable patients.
  • Pre-procedural risk assessment and tailored closure strategies are crucial.

Conclusions:

  • Transcatheter ASD closure is feasible in select patients with LV dysfunction.
  • Minimizing complications involves comprehensive risk assessment and individualized management.
  • Further research may refine optimal strategies for this patient population.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
605
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
424
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.2K
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
516
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
418
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
916